Synthetic chenodeoxycholic acid derivatives inhibit glioblastoma multiform tumor growth in vitro and in vivo

International Journal of Oncology

Volumn 27, Issue 3, 2005, Pages 653-659

  Yee, Su Bog ^a   Yeo, Won Jae ^b   Park, Bong Soo ^b   Kim, Ji Young ^a   Baek, Soo Jin ^a   Kim, Yoon Cheong ^a   Seo, Su Young ^a   Lee, Sang Hwa ^a   Kim, Jae Hong ^c   Suh, Hongsuk ^c   Kim, Nam Deuk ^d   Lim, Young Jin ^a   Yoo, Young Hyun ^a  

^a Dong A University College of Medicine   (South Korea)

^b Department of Oral Microbiology and Immunology   (South Korea)

^c Department of Chemistry   (South Korea)

^d Pusan National University   (South Korea)

Author keywords

Apoptosis; Chenodeoxycholic acid; Glioblastoma; HS 1199; HS 1200

Indexed keywords

CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, MOUSE; CASPASE; CASPASE 3; CHENODEOXYCHOLIC ACID; DNA FRAGMENT; DRUG DERIVATIVE; HS 1199; HS 1200; HS-1199; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CELL NUCLEUS; CELL SURVIVAL; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVATION; GLIOBLASTOMA; HUMAN; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; SURVIVAL; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; CHENODEOXYCHOLIC ACID; DNA FRAGMENTATION; ENZYME ACTIVATION; GLIOBLASTOMA; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; POLY(ADP-RIBOSE) POLYMERASES; SURVIVAL ANALYSIS; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 24344433997     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Hofmann AF: Chemistry and enterohepatic circulation of bile acids (Review). Hepatology 4 (Suppl. 5): S4-S14, 1984.
2. Martinez JD, Stratagoules ED, La Rue JM, Powell AA, Gause PR, Craven MT, Payne CM, Powell MB, Gerner EW and Earnest DL: Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr Cancer 31: 111-118, 1998.
3. Jones B, Roberts PJ, Faubion WA, Kominami E and Gores GJ: Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am J Physiol 275: G723-G730, 1998.
4. Martinez-Diez MC, Serrano MA, Monte MJ and Marin JJ: Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture. Biochim Biophys Acta 1500: 153-160, 2000.
5. Rust C, Karnitz LM, Paya CV, Moscat J, Simari RD and Gores GJ: The bile acid taurocheno-deoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 275: 20210-20216, 2000.
6. Patel T, Bronk SF and Gores GJ: Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 94: 2183-2192, 1994.
7. Patel T, Roberts LR, Jones BA and Gores GJ: Dysregulation of apoptosis as a mechanism of liver disease: an overview. Semin Liver Dis 18: 105-114, 1998.
8. Powell AA, La Rue JM, Batta AK and Martinez JD: Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells. Biochem J 356: 481-486, 2001.
9. Kim ND, Im EO, Choi YH and Yoo YH: Synthetic bile acids: novel mediators of apoptosis. J Biochem Mol Biol 35: 134-141, 2002.
10. Im EO, Lee S, Suh H, Kim KW, Bae YT and Kim ND: A novel ursodeoxycholic acid derivative induces apoptosis in human MCF-7 breast cancer cells. Pharm Pharmacol Commun 5: 293-298, 1999.
11. Im EO, Choi YH, Paik KJ, Suh H, Jin Y, Kim KW, Yoo YH and Kim ND: Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells. Cancer Lett 163:83-93,2001.
12. Choi YH, Im EO, Suh H, Jin Y, Lee WH, Yoo YH, Kim KW and Kim ND: Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases. Int J Oncol 18:979-984,2001.
13. Choi YH, Im EO, Suh H, Jin Y, Yoo YH and Kim ND: Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. Cancer Lett 199: 157-167, 2003.
14. Park SE, Choi HJ, Yee SB, Chung HY, Suh H, Choi YH, Yoo YH and Kim ND: Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells. Int J Oncol 25: 231-236, 2004.
15. Seo SY, Jun EJ, Jung SM, Kim KH, Lim YJ, Park BS, Kim, JK, Lee S, Suh H, Kim ND and Yoo YH: Synthetic chenodeoxycholic acid derivative HS-1200-induced apoptosis of p815 mastocytoma cells is augmented by co-treatment with lactacystin. Anticancer Drugs 14: 219-225, 2003.
16. Jeong JH, Park JS, Moon B, Kim MC, Kim JK, Lee S, Suh H, Kim ND, Kim JM, Park YC and Yoo YH: Orphan nuclear receptor Nur77 translocates to mitochondria in the early phase of apoptosis induced by synthetic chenodeoxycholic acid derivatives in human stomach cancer cell line SNU-1. Ann NY Acad Sci 1010: 171-177,2003.
17. Suh H, Jung EJ, Kim TH, Lee HY, Park YH and Kim KW: Anti-angiogenic activity of ursodeoxycholic acid and its derivatives. Cancer Lett 113: 117-122, 1997.
18. Im E, Choi S, Suh H, Choi YH, Yoo YH and Kim ND: Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-ÎB-dependent process in human cervical carcinoma cells. Cancer Lett (In press).
19. Alonso M, Tamasdan C, Miller DC and Newcomb EW: Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway. Mol Cancer Ther 2: 139-150, 2003.
20. Choi HJ, Kim HH, Lee HS, Huh GY, Seo SY, Jeong JH, Kim JM and Yoo YH: Lactacystin augments the sulindac-induced apoptosis in HT-29 cells. Apoptosis 8: 301-305, 2003.
21. Yoon HS, Rho JH, Yoo KW, Park WC, Rho SH, Choi YH, Suh H, Kim ND, Yoo KS and Yoo YH: Synthetic bile acid derivatives induce nonapoptotic death of human retinal pigment epithelial cells. Curr Eye Res 22: 367-374, 2001.
22. Drexler HC, Risau W and Konerding MA: Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB J 14: 65-77, 2000.
23. Orlowski RZ: The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 6: 303-313, 1999.
24. Grimm LM, Goldberg AL, Poirier GG, Schwartz LM and Osborne BA: Proteasomes play an essential role in thymocyte apoptosis. EMBO J 15: 3835-3844, 1996.
25. Sadoul R, Fernandez PA, Quiquerez AL, Martinou I, Maki M, Schroter M, Becherer JD, Irmler M, Tschopp J and Martinou JC: Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J 15: 3845-3852, 1996.
26. Li B and Dou QP: Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proc Natl Acad Sci USA 97: 3850-3855, 2000.
27. Orlowski RZ, Eswara JR, Lafond-Walker A, Grever MR, Orlowski M and Dang CV: Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor. Cancer Res 58: 4342-4348, 1998.
28. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S and Elliott PJ: Proteasome inhibitors: a novel class of potent and effective antitumoragents. Cancer Res 59: 2615-2622, 1999.
29. Chandra J, Niemer I, Gilbreath J, Kliche KO, Andreeff M, Freireich EJ, Keating M and McConkey DJ: Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes. Blood 92: 4220-4229, 1998.
30. Delic J, Masdehors P, Omura S, Cosset JM, Dumont J, Binet JL and Magdelenat H: The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alphainitiated apoptosis. Br J Cancer 77: 1103-1107, 1998.
31. Fanelli M, Minucci S, Gelmetti V, Nervi C, Gambacorti- Passerini C and Pelicci PG: Constitutive degradation of PML/RARalpha through the proteasome pathway mediates retinoic acid resistance. Blood 93: 1477-1481, 1999.
32. Golab J, Stoklosa T, Czajka A, Dabrowska A, Jakobisiak M, Zagozdzon R, Wojcik C, Marczak M and Wilk S: Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice. Anticancer Res 20: 1717-1721, 2000.
33. Park BS, Baek SJ, Song KH, Kim KH, Jeong SJ, Jeong MH, Seo SY, Lee SW, Yoo KS and Yoo YH: Genistein-induced apoptosis of p815 mastocytoma cells is mediated by Bax and augmented by a proteasome inhibitor, lactacystin. Nutr Cancer 42: 248-255, 2002.
34. Kroemer G, Zamzami N and Susin SA: Mitochondrial control of apoptosis. Immunol Today 18: 44-51, 1997.
35. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
36. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM and Kroemer G: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446, 1999.
37. Orrenius S: Mitochondrial regulation of apoptotic cell death. Toxicol Lett 149: 19-23, 2004.
38. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997.
39. Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH and Weller M: Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem 75: 2288-2297, 2000.
40. Marshansky V, Wang X, Bertrand R, Luo H, Duguid W, Chinnadurai G, Kanaan N, Vu MD and Wu J: Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J Immunol 166: 3130-3142, 2001.
41. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J and Kroemer G: Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14: 729-739, 2000.
42. Liu X, Li P, Widlak P, Zou H, Luo X, Garrard WT and Wang X: The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci USA 95: 8461-8466, 1998.